HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: jnumed.107.039602v1 48/6/987    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cheng, Z. Articles by Gambhir, S. S. Search for Related Content PubMed PubMed Citation Articles by Cheng, Z. Articles by Gambhir, S. S.

Small-Animal PET of Melanocortin 1 Receptor Expression Using a ¹⁸F-Labeled -Melanocyte-Stimulating Hormone Analog

¹ Molecular Imaging Program at Stanford (MIPS), Stanford University, Stanford, California; ² Department of Radiology, Stanford University, Stanford, California; ³ Bio-X Program, Stanford University, Stanford, California; ⁴ Department of Radiation Oncology, Stanford University, Stanford, California; ⁵ Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai, China; and ⁶ Department of Bioengineering, Stanford University, Stanford, California

Correspondence: For correspondence contact: Zhen Cheng, PhD, Molecular Imaging Program at Stanford, Department of Radiology and Bio-X Program, Stanford University, 318 Campus Dr., Clark Center, E-150, Stanford, CA 94305. E-mail: zcheng{at}stanford.edu

¹⁸F-Labeled small synthetic peptides have emerged as attractive probes for imaging various molecular targets with PET. The -melanocyte-stimulating hormone (-MSH) receptor (melanocortin type 1 receptor [MC1R]) is overexpressed in most murine and human melanomas. It is a promising molecular target for diagnosis and therapy of melanomas. However, ¹⁸F compounds have not been successfully developed for imaging the MC1R. Methods: In this study, an -MSH analog, Ac-Nle-Asp-His-D-Phe-Arg-Trp-Gly-Lys-NH₂ (NAPamide), was radiolabeled with N-succinimidyl-4-¹⁸F-fluorobenzoate (¹⁸F-SFB). The resulting radiopeptide was evaluated as a potential molecular probe for small-animal PET of melanoma and MC1R expression in melanoma xenografted mouse models. Results: The binding affinity of ¹⁹F-SFB–conjugated NAPamide, ¹⁹F-FB-NAPamide, was determined to be 7.2 ± 1.2 nM (mean ± SD) using B16/F10 cells and ¹²⁵I-(Tyr²)-[Nle⁴,D-Phe⁷]--MSH [¹²⁵I-(Tyr²)-NDP] as a radioligand. The biodistribution of ¹⁸F-FB-NAPamide was then investigated in C57BL/6 mice bearing subcutaneous murine B16/F10 melanoma tumors with high expression of MC1Rs and Fox Chase Scid mice bearing human A375M melanoma with a relatively low number of MC1R receptors. Biodistribution experiments showed that tumor uptake values (percentage injected dose per gram of tumor [%ID/g]) of ¹⁸F-FB-NAPamide were 1.19 ± 0.11 %ID/g and 0.46 ± 0.11 %ID/g, in B16/F10 and A375M xenografted melanoma at 1 h after injection, respectively. Furthermore, the B16/F10 tumor uptake was significantly inhibited by coinjection with excess -MSH peptide (P < 0.05), indicating that ¹⁸F-FB-NAPamide specifically recognizes the MC1R in living mice. Small-animal PET of ¹⁸F-FB-NAPamide in mice bearing B16/F10 and A375M tumors at 1 h after tail vein injection revealed good B16/F10 tumor-to-background contrast and low A375M tumor-to-background ratios. Conclusion: ¹⁸F-FB-NAPamide is a promising molecular probe for -MSH receptor-positive melanoma PET and warrants further study.

Key Words: melanoma • -melanocyte-stimulating hormone • PET • imaging • ¹⁸F

COPYRIGHT © 2007 by the Society of Nuclear Medicine, Inc.

Related articles in JNM:

This Month in JNM

JNM 2007 48: 11a-12a. [Full Text]  

This article has been cited by other articles:

				G. Ren, Z. Liu, Z. Miao, H. Liu, M. Subbarayan, F. T. Chin, L. Zhang, S. S. Gambhir, and Z. Cheng PET of Malignant Melanoma Using 18F-Labeled Metallopeptides J. Nucl. Med., November 1, 2009; 50(11): 1865 - 1872. [Abstract] [Full Text] [PDF]

				G. Ren, Z. Miao, H. Liu, L. Jiang, N. Limpa-Amara, A. Mahmood, S. S. Gambhir, and Z. Cheng Melanin-Targeted Preclinical PET Imaging of Melanoma Metastasis J. Nucl. Med., October 1, 2009; 50(10): 1692 - 1699. [Abstract] [Full Text] [PDF]